Company / Profit Margin
Veracyte, Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
12.8%
FY2025
5-year range
-34.4% / 12.8%
FY2021-FY2025
Trend
+137.2%
vs FY2024
Sector context
#26 of 150
Health Care
What the data says
Veracyte, Inc.'s profit margin of 12.8% is higher than 83% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 8 years, ranging from -34.4% in FY2021 to 12.8% in FY2025.
Based on SEC 10-K filings.
12.8% in FY2025 with a 5-year CAGR of +42.5%. Top quartile in the Health Care sector.
Improved from -20.6% to 12.8% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +25.2pp
- 5-Year Change
- +42.5pp
- 10-Year Change
- -
Sector benchmark
Top 17% in Health CareTop 17% of 150This company 12.8% Sector average -263.0%
▼
+104.9% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 137.2% year-over-year.
- Currently 275.8pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.8% | +137.2% |
| FY2024 | 5.4% | +126.2% |
| FY2023 | -20.6% | -67.2% |
| FY2022 | -12.3% | +64.2% |
| FY2021 | -34.4% | -15.9% |
| FY2020 | -29.7% | -183.8% |
| FY2019 | -10.5% | +58.1% |
| FY2018 | -25.0% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026